Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00333268 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus
A Phase 3 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 369
- Enrollment target
NCT00333268 is a Phase 3 study that has completed, run by Alcon Research. The registered enrollment target is 369 participants.
The verdict
NCT00333268, a Phase 3 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 369 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and efficacy of Next Generation Ophthalmic Irrigating Solution (NGOIS) compared to BSS Plus for use during cataract extraction and intra-ocular lens (IOL) implantation.
Interventions
- DRUG BSS Plus
- DRUG Next Generation Ophthalmic Irrigating Solution (NGOIS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 369 participants |
| Start Date | 2004-09 |
| Est. Completion | 2005-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00333268
The ClinicalTrials.gov registry entry for NCT00333268 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 369 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BSS Plus is the first listed.
NCT00333268 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00333268 about?
NCT00333268 is a clinical study titled "Safety and Efficacy of Next Generation Ophthalmic Irrigating Solution Compared to BSS Plus". The purpose of this study is to determine the safety and efficacy of Next Generation Ophthalmic Irrigating Solution (NGOIS) compared to BSS Plus for use during cataract extraction and intra-ocular lens (IOL) implantation.
What is the current status of trial NCT00333268?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 369 participants. The study started on 2004-09. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00333268?
The interventions under investigation include: BSS Plus (DRUG), Next Generation Ophthalmic Irrigating Solution (NGOIS) (DRUG).
Who is sponsoring clinical trial NCT00333268?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.